^
BIOMARKER:

KRAS G12

i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Entrez ID:
Related biomarkers:
KRAS G12
CRC
cetuximab
Resistant: A1 - Approval
KRAS G12
Ovarian Cancer
cetuximab
Resistant: C1 - Off-label
KRAS G12
CRC
bevacizumab
Sensitive: C3 – Early Trials
KRAS G12
CRC
AZD1775
Sensitive: C3 – Early Trials
KRAS G12
CRC
RTB101
Sensitive: D – Preclinical
KRAS G12
CRC
selumetinib + RTB101
Sensitive: D – Preclinical
KRAS G12
CRC
selumetinib
Sensitive: D – Preclinical